ARCHIVES

Retrospective Data Clean-up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Morgan Named Director Of UAMS Myeloma Institute

April 25, 2014

CTI Files Appeal Over FDA’s Decision on Pixantrone

December 3, 2010

Also in this 12-page issue: GM Cancer Research Foundation awards annual prizes to four scientists.

June 4, 2004

Other News: ESAs Fail To Reduce Blood Transfusions, SEER Data Show

November 20, 2009

DCBDC Advisors Set aside $2 Mil. For Research On The Microenvironment of Breast Cancer

July 9, 1993

The March: Research Task Force Calls For $10 Billion For NCI In 5 Years

October 23, 1998